| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Promazine (substance) |
Is a |
True |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine hydrochloride 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine hydrochloride 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine hydrochloride 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine hydrochloride 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine hydrochloride 25mg/5mL s/f oral solution (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine hydrochloride 100mg/5mL s/f oral solution (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine hydrochloride 100mg/5mL s/f suspension (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely chlorpromazine (as chlorpromazine hydrochloride) 100 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| chlorhydrate de chlorpromazine 25 mg/mL, ampoule de 2 mL de solution pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine hydrochloride 50mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine hydrochloride [nausea] [see dh2..] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine hydrochloride [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely chlorpromazine (as chlorpromazine hydrochloride) 25 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine 50 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine 300 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Oral chlorpromazine (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine hydrochloride 10mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely chlorpromazine hydrochloride 200 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine hydrochloride 25mg injection solution 1mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Oral form chlorpromazine m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine hydrochloride 30mg capsule sustained release |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine hydrochloride 75mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Chlorpromazine hydrochloride 150mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Alimemazine |
Is a |
True |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levomepromazine |
Is a |
True |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlorpromazine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing propylamino derivative of phenothiazine (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Promazine hydrochloride |
Is a |
True |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Methotrimeprazine maleate |
Is a |
True |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Alimemazine tartrate |
Is a |
True |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Levomepromazine hydrochloride |
Is a |
True |
Propylamino derivative of phenothiazine (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]